Pharmaceutical

Who thinks outside the box to get more in it?

北京快三开奖结果彩票控 www.8hib.cn We do.

Our pharmaceutical team prides itself on advancing drug delivery with sophisticated science-based solutions. Our global centers of excellence contain the latest equipment and our research scientists and formulators are ready to work with you from concept to commercialization.

Now sold as Klucel™, Ashland introduced hydroxypropylcellulose (HPC) - an excipient that changed the drug delivery platform - to the market 65 years ago. And while others have followed, it was the solvers at Ashland who discovered it. Our full line of products combined with our global research and development capabilities can help deliver your drugs when and where they're needed resulting in better outcomes for patients and pharmaceutical companies alike.

With its significant history in pharmaceuticals and one of the widest available range of products for oral solid-dosage forms Ashland has a solid foundation to help find excipient and formulation solutions for you. Our global manufacturing sites, that operate in accordance with cGMP standards, provide consistently high quality products regardless of origin. As a full-service resource, Ashland can help you bind, coat, dissolve and deliver solutions that can yield better patient outcomes.

an overview of our pharmaceutical focus

Ashland solver and R&D Director of Pharmaceutical and Health & Wellness, Dr. Thomas Durig, discusses our latest innovations and solutions.

 

read more >

  • Oral Solid Dosage Form

    Prescriptions for successful solutions

    While an apple a day keeps the doctor away (and the teacher happy) there comes a time, in almost everyone's life, when medication - in tablet form - is needed.  Our knowledge of the structure function of polymers, combined with our extensive product line can help you bind, coat, dissolve, and effectively deliver complex drug molecules where and when they're needed - making medication easier to swallow.  And, easy to swallow medication often yields better patient compliance,  which, in turn, yields better outcomes for everyone - a winning scenario. From concept to commericialization, working with Ashland makes medicine easy to swallow.

    Ashland is unsurpassed in its ability to develop solutions for effective and efficient solutions to deliver today's complex drug molecules where and when they are needed.  Our centers of excellence and manufacturing sites operate in accordance with cGMP standards. Our various chemistries and technologies are supported by a global team of research and development scientists. Ashland stands ready collaborate with you on new solutions to help take you from concept to commercialization.  Our solutions include:

    • Increasing the solubility of active pharmaceutical ingredients with low or no solubility
    • Designing modified-release products to meet targeted release profiles
    • Reducing tablet size while maintaining active pharmaceutical ingredient load
    • Improving disintegration time of orally disintegrating tablets
    • Understanding implications of continuous manufacturing technology for oral dosage production

    Ongoing research provides a foundation for advanced technical solutions to address these and future formulation and manufacturing challenges. Ashland provides formulators with industry-changing technologies and unique opportunities for research and development collaboration.

     

    Read More >
  • Oral Liquid Dosage Form

    Ashland helps the medicine go down

    A spoonful of sugar may help the medicine go down, but the folks at Ashland, with their expertise in pharmaceutical formulations, know that there's more to it.   Effective drug delivery in liquid form poses some unique challenges with rheology, texture, consistency and stability at the top of the list.  Ashland's promise - always solving™ - inspires our goal of willing to work with you to find new sophisticated solutions to advance drug delivery. With our extensive polymer portfolio, R&D capabilities and testing facilities combined with your complex drug molecues, we can yield solutions that both deliver and improve the bioavailability of needed medication.

    Targeted rheology, texture and stabilization in oral-liquid dosage forms play vital roles in delivery of the pharmaceutical components. The water binding and viscosity modification capacities of many of Ashland’s polymers thicken and suspend in liquids, gels, syrups and semi-solid dosage forms for improved patient satisfaction and shelf life of products. Contact us to learn more.

    Read More >
  • Other Dosage Form

    Solutions that are more than skin deep

    Our solutions are more than skin deep.  Through transdermal and topical  applications, skin can be an effective way to deliver some medications.   Regardless of whether the drug is being delivered via gel, lotion, cream, ointment or foam, features including texture, adhesion,  and spreadability, as well as feel and smell, are important attributes to  consider for optimal patient compliance. For topical and transdermal application, Ashland's pharmacuetical team works with the talented skin care team to find alluring and luxurious ways to effectively and efficiently formulate topical and transdermal applications.

    Topical treatments are administered to skin or mucous membranes to alleviate a variety of conditions. These treatments broadly encompass creams, foams, gels, lotions and ointments. There are a number of sought-after attributes for conferring desired properties to a topical formulation: rheology control, spreadability, adhesion and diffusion control. Ashland offers high-quality cellulose ethers such as Natrosol™ 250 hydroxyethylcellulose, Klucel™ hydroxypropylcellulose and Aqualon™ sodium carboxymethylcellulose to deliver these properties. Some of the topical film formers offered in our skin-care product lines are also suitable for use in topical applications. Plasdone™ povidone is also a good film former for topical applications. Contact us to learn more about our solutions for topical and transdermal applications.

    Read More >

learn more about our solutions


Related Content

  • 《朝圣之路》第三季直面邪教争议性问题 2019-03-31
  • 中国公民可72小时免签停留俄大城市?中俄正在协商 2019-03-31
  • 人民空军奋力投身改革强军 加快推进战略转型 2019-03-28
  • 聚焦三大任务 走好新征程 2019-03-28
  • 很容易让人联想到是这个女人的错,而杨杨忽视其背后有很复杂的原因。 2019-03-24
  • 用“调图”织密百姓幸福网 2019-03-24
  • 幸福感,在改革的春风里成长 2019-03-11
  • 中超两将或联袂登场 非洲雄鹰能否再演黑马本色 2019-03-11
  • 国外看中国科技:中国隧道技术发展迅速享誉世界 2019-03-10
  • 乌鲁木齐:乐享假日好时光 2019-03-10
  • 广州市白云区人民法院公告专栏 2019-02-15
  • 小米收购其韩国总代 在三星“后花园”落地 2019-02-01
  • 朔州检察院新机制助力企业家创业 2019-01-16
  • 人要是不知道廉耻,和你有什么区别! 2019-01-16
  • 国家体育总局局长:国家队员选拔要取消领导干预、杜绝暗箱操作 2018-12-15
  • 174| 902| 52| 379| 753| 53| 151| 829| 598| 908|